In Brief: Meretek's UBT
This article was originally published in The Gray Sheet
Executive Summary
Meretek's UBT: H. pylori breath test receives FDA clearance to monitor the post-treatment status of the ulcer-causing bacterium in adult patients who have received antibiotic therapy, the Nashville, Tennessee-based firm says. The test was cleared by FDA in September 1996 to detect the presence or absence of an active H. pylori infection ("The Gray Sheet," Sep. 23, 1996, I&W-7)...